Discover the CRPS certification, its role in retirement planning for businesses, exam details, benefits, and ongoing ...

A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer ...

Abiogen Pharma is a recognized leader in the discovery and development of bisphosphonates including the advancement of neridronate. Neridronate was approved in Italy based on the safety and efficacy ...

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech.  | Vivek Ramaswamy has found ...

Bisphosphonates may reduce complex regional pain syndrome (CRPS) pain intensity in the short term, according to a study ...

BRC Therapeutics (BRC), a pharmaceutical company developing proprietary therapeutics for neurological and inflammatory diseases, celebrates yesterday's landmark executive order that would remove ...

When Marilyn Conner shattered her left hand, she developed intense chronic pain. Nothing helped until she tried spinal cord ...

Ambros Therapeutics’ non-opioid bisphosphonate analgesic, already approved in Italy, will soon begin a pivotal test in the ...

Our roundup of financings in the biotech arena this week is led by a $125 million Series A for Ambros Therapeutics, a startup ...

A systematic review of 17 randomized trials found that among high cardiovascular risk individuals, reducing saturated fat was linked to lower all-cause mortality and possible reductions in ...

The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...

Ramaswamy’s latest startup, Ambros Therapeutics, launched Tuesday with plans to develop a treatment for a rare form of the ...